EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

Ohoud Aljuhani, Ghazwa B Korayem, Ali F Altebainawi, Meshal S Alotaibi, Noura A Alrakban, Ragia H Ghoneim, Ramesh Vishwakarma, Abdulrahman I Al Shaya, Shmeylan Al Harbi, Jawaher Gramish, Dahlia M Almutairi, Ghada Alqannam und 8 weitere

Saudi Pharmaceutical Journal · 2023-07 · 31 (7) · 1210-1218

DOI: 10.1016/j.jsps.2023.05.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2023-07. Verfasst von Ohoud Aljuhani und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Princess Nourah Bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Critically illIntensive care unitMechanical ventilation durationMortalityOseltamivirViral clearance

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia.
  • Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia.
  • Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
  • Statistics Department, European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Förderung

  • Princess Nourah Bint Abdulrahman University

Zitieren

APA

Aljuhani, O., Korayem, G. B., Altebainawi, A. F., Alotaibi, M. S., Alrakban, N. A., Ghoneim, R. H., Vishwakarma, R., Al Shaya, A. I., Al Harbi, S., Gramish, J., Almutairi, D. M., Alqannam, G., Alamri, F. F., Alharthi, A. F., Alfaifi, M., Al Amer, A., Alenazi, A. A., Bin Aydan, N., Alalawi, M., & Al Sulaiman, K. (2023). The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study. Saudi Pharmaceutical Journal, 31(7), 1210-1218. https://doi.org/10.1016/j.jsps.2023.05.006

Vancouver

Aljuhani O, Korayem GB, Altebainawi AF, Alotaibi MS, Alrakban NA, Ghoneim RH, et al. The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study. Saudi Pharmaceutical Journal. 2023;31(7):1210-1218. doi:10.1016/j.jsps.2023.05.006

BibTeX
@article{Aljuhani2023,
  author = {Aljuhani, Ohoud and Korayem, Ghazwa B and Altebainawi, Ali F and Alotaibi, Meshal S and Alrakban, Noura A and Ghoneim, Ragia H and Vishwakarma, Ramesh and Al Shaya, Abdulrahman I and Al Harbi, Shmeylan and Gramish, Jawaher and Almutairi, Dahlia M and Alqannam, Ghada and Alamri, Faisal F and Alharthi, Abdullah F and Alfaifi, Mashael and Al Amer, Abdullah and Alenazi, Abeer A and Bin Aydan, Norah and Alalawi, Mai and Al Sulaiman, Khalid},
  title = {The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study},
  journal = {Saudi Pharmaceutical Journal},
  year = {2023},
  volume = {31},
  number = {7},
  pages = {1210--1218},
  doi = {10.1016/j.jsps.2023.05.006}
}
Kostenlos starten →